Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 240 shares at $2.82 ($677) on 2008-08-04, disclosed to the SEC on 2008-08-04.
Open-market purchase of $677 BCRX by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2022-12-19 | $154K | — | Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |